Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 2,713-2,724 of 10,612

Drug study icon

CompletedNCT03605836

A study Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: ADHD

Drug study icon

CompletedNCT03287869

Brexpiprazole for Bipolarity

This study is completed in the United States, in Bulgaria, in Croatia, .... It is testing brexpiprazole for Bipolarity.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States, Bulgaria, Croatia, ...
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Bipolarity

Drug study icon

TerminatedNCT03643159

A study to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolarity type I, and Major Depressive Disorder

This study was terminated in the United States. It focuses on depression.

Remote / online

Depression, Bipolarity, ...DrugFrom 18 Years to 63 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Depression, Bipolarity, ...

Drug study icon

CompletedNCT07305779

A study to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT01566162

A Twelve Week, Open Label Extension Study in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 18 Years

Countries: United States, France, Italy, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT00208156

A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, SchizophreniaDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Corcept Therapeutics
Condition: Depression, Schizophrenia

Drug study icon

CompletedNCT00130676

A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, SchizophreniaDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Corcept Therapeutics
Condition: Depression, Schizophrenia

Drug study icon

CompletedNCT00128479

A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, SchizophreniaDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Corcept Therapeutics
Condition: Depression, Schizophrenia

Device study icon

CompletedNCT04025671

A Usability Assessment of Naloxone Administration by Untrained Community Members

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDeviceOver 18 Years

Countries: United States
Sponsor: State University of New York - Upstate Medical University
Condition: Addiction

Behavioral study icon

CompletedNCT01399112

A Usability Study of a Smoking Cessation Decision Aid in People With a Recent First Episode of Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaBehavioralFrom 15 Years to 30 Years

Countries: United States
Sponsor: Northwell Health
Condition: Schizophrenia

Behavioral study icon

CompletedNCT04148521

A Virtual Navigation Intervention to Reduce Behavioral Health Admissions From Rural Emergency Departments

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

Addiction, Depression, ...BehavioralOver 18 Years

Countries: United States
Sponsor: Wake Forest University Health Sciences
Condition: Addiction, Depression, ...

Behavioral study icon

CompletedNCT04845347

A Wearable Morning Light Treatment for Postpartum Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionBehavioralOver 18 Years

Countries: United States
Sponsor: University of Michigan
Condition: Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.